Goldman Sachs Group Inc Pfizer Inc Transaction History
Goldman Sachs Group Inc
- $580 Billion
- Q2 2024
A detailed history of Goldman Sachs Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 34,916,739 shares of PFE stock, worth $959 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
34,916,739
Previous 22,347,154
56.25%
Holding current value
$959 Million
Previous $620 Million
57.54%
% of portfolio
0.17%
Previous 0.11%
Shares
18 transactions
Others Institutions Holding PFE
# of Institutions
3,253Shares Held
3.72BCall Options Held
73.5MPut Options Held
108M-
Vanguard Group Inc Valley Forge, PA511MShares$14 Billion0.28% of portfolio
-
Black Rock Inc. New York, NY424MShares$11.7 Billion0.27% of portfolio
-
State Street Corp Boston, MA287MShares$7.88 Billion0.36% of portfolio
-
Wellington Management Group LLP Boston, MA166MShares$4.57 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA117MShares$3.22 Billion0.63% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $154B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...